9-ING-41 in Patients With Advanced Cancers
Trial details
- Registry ID
- NCT03678883
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Gemzar
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| 9-ING-41 in Patients With Advanced CancersNCT03678883 | ACTU | Phase 2 | Active not recruiting | 2026-06Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |